Hormonally, LP suppressed hyperandrogenism, as evidenced by decreased testosterone, while rebalancing inflammatory mediators through IL-10 upregulation and concomitant reduction of TNF-<i>α</i>, IL-6, IL-1β, and MCP-1. The gene discussed is IL1B; the disease is hyperandrogenism.